Cart
sales@molnova.com
SCD1 inhibitor-4
CAS No. 1295541-87-5
SCD1 inhibitor-4( —— )
Catalog No. M23453 CAS No. 1295541-87-5
SCD1 inhibitor-4 is stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 58 | In Stock |
|
| 5MG | 87 | In Stock |
|
| 10MG | 158 | In Stock |
|
| 25MG | 320 | In Stock |
|
| 50MG | 515 | In Stock |
|
| 100MG | 740 | In Stock |
|
| 500MG | 1521 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSCD1 inhibitor-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionSCD1 inhibitor-4 is stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes.
-
DescriptionSCD1 inhibitor-4 is stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes.
-
In Vitro——
-
In VivoSCD1 inhibitor-4 (1~30 mg/kg) shows a dose-dependent decrease in desaturation index with a 55 % reduction at 1 mg/kg and 85% reduction at the 10 and 30 mg/kg doses.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorSCD1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1295541-87-5
-
Formula Weight363.34
-
Molecular FormulaC17H16F3N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL?(247.70 mM;?Need ultrasonic)
-
SMILESO=C(C1=C(C)N(CC2=CC=CC(C(F)(F)F)=C2)C=N1)NC3=NN(C)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Atkinson KA, et al. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorg Med Chem Lett. 2011;21(6):1621-1625.
molnova catalog
related products
-
TC HSD 21
TC HSD 21 is a potent and highly selective inhibitor of 17β-hydroxysteroid dehydrogenase type 3 (IC50 = 14 nM).
-
IDH2R140Q-IN-2
IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation (IC50 of 10 nM) and inhibiting tumour tissue D2HG levels.
-
WAY-324168
WAY-324168 is a compound with antiproliferative activity.
